Abstract
The insulin-like growth factor signaling system has been implicated in cancer etiology, progression, and metastasis. This signaling system involves a network of highly related ligands and receptors. Targeting of this system is complex; multiple receptors, including the insulin receptor, are involved. Further, holo- and hybrid receptors must be considered when considering therapeutic strategies. This review will evaluate the signaling pathways mediated by this system.
Original language | English (US) |
---|---|
Title of host publication | Predictive Biomarkers in Oncology |
Subtitle of host publication | Applications in Precision Medicine |
Publisher | Springer International Publishing |
Pages | 283-288 |
Number of pages | 6 |
ISBN (Electronic) | 9783319952284 |
ISBN (Print) | 9783319952277 |
DOIs | |
State | Published - Jan 1 2018 |
Bibliographical note
Publisher Copyright:© Springer Nature Switzerland AG 2019.
Keywords
- Insulin
- Insulin receptor
- Insulin-like growth factors
- Type I insulin-like growth factor receptor
- Tyrosine kinase